The global impact of the COVID-19 pandemic has been profound and enduring, with its complete spectrum still unfolding. Initial reports indicated eye redness and irritation in COVID-19 patients, suggesting conjunctivitis as an ocular symptom of SARS-CoV-2 infection. Recent research links COVID-19 to uveitic, retinovascular, and neuro-ophthalmic conditions. The virus can infect unprotected eyes, as evident in patient eye examinations. Ocular side effects are also associated with COVID-19 treatments, though long-term damage akin to chloroquine and hydroxychloroquine treatment is not anticipated.